CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Dec. 30, 2016		Jan. 01, 2016
Cash flows from operating activities:
Net earnings	$ 21.0		$ 89.0
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	11.5		11.3
Tax benefits from exercises of share-based payment awards	0.4		1.0
Excess tax benefits from share-based compensation	(0.5)		(1.1)
Depreciation	17.2		15.5
Amortization of intangible assets	5.1		3.0
Deferred taxes	(19.1)		(3.2)
Provision for doubtful accounts receivable	38.1		4.0
Impairment charges	38.3		0.0
Other, net	(0.5)		1.1
Changes in assets and liabilities:
Accounts receivable	31.0		(29.5)
Inventories	(28.2)		(4.0)
Prepaid expenses and other assets	(5.0)		(12.0)
Accounts payable	(20.7)		(14.1)
Accrued liabilities and other long-term liabilities	(20.8)		5.3
Deferred revenues	14.4		11.0
Net cash provided by operating activities	82.2		77.3
Cash flows from investing activities:
Purchases of property, plant and equipment	(17.2)		(27.3)
Issuance of notes receivable	(11.4)		(2.1)
Sale of available-for-sale securities	0.0		8.6
Investment in available-for-sale securities	(0.6)		(0.9)
Amounts paid to deferred compensation plan trust account	(3.4)		(2.7)
Other	0.8		0.1
Net cash used in investing activities	(31.8)		(24.3)
Cash flows from financing activities:
Repurchases of common stock	(49.5)		(192.1)
Proceeds from issuance of common stock to employees	16.1		15.3
Excess tax benefits from share-based compensation	0.5		1.1
Employees' taxes withheld and paid for restricted stock and restricted stock units	(1.2)		(4.5)
Borrowings under credit facility agreement	10.0		75.0
Repayments under credit facility agreement	(10.0)		(67.5)
Net (repayments) borrowings under the credit facility agreements with maturities less than 90 days	(55.0)		225.0
Contingent consideration and hold back	(0.5)		(2.5)
Net cash (used in) provided by financing activities	(89.6)		49.8
Effects of exchange rate changes on cash and cash equivalents	10.4		5.1
Net (decrease) increase in cash and cash equivalents	(28.8)		107.9
Cash and cash equivalents at beginning of period	843.5	[1]	845.5
Cash and cash equivalents at end of period	$ 814.7		$ 953.4

[1] The condensed consolidated balance sheet as of September 30, 2016 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.